Corcept Therapeutics’ relacorilant plus nab-paclitaxel shows positive results in ovarian cancer
Ovarian cancer is the fifth leading cause of deaths from cancer in women
Read More
Author: Esme Needham
ErVimmune raises 17m euros in funding to develop cancer vaccine
The vaccine could be created as a ready-to-use product, rather than needing to be personalised
Read More
Sun Pharma’s Unloxcyt now available in US for advanced cutaneous squamous cell carcinoma
More than 71% of patients treated with Unloxcyt achieved disease control
Read More
Peter Llewellyn-Davies
ARTCLINE appoints Peter Llewellyn-Davies as Chairman of its Supervisory Board
Read More
Venner Shipley announces opening of new Bristol office
The firm already has a number of offices across the UK and Europe
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
